Ferric Citrate
2 NDCs across 2 manufacturers|1 Generic,1 Brand
Ferric Citrate is used to treat iron-deficiency anemia and hematologic pregnancy complications, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 5, 2014, and the first generic was approved Mar 11, 2026. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $132 million on Ferric Citrate across 73,000 claims for 17,000 beneficiaries.
Ferric Citrate is available as 2 NDCs from 2 manufacturers (1 generic, 1 brand), with NADAC prices from $6.28 to $7.48 per EA — a 19% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
1G / 1B
Manufacturers
2
competing in market
Price Spread
$6.28 – $7.48
per EA
7d Activity
avg +0.3% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Akebia Therapeutics, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Parenteral Iron Replacement class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing FERRIC CITRATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
AURYXIA 210 MG TABLET | $7.4809 per EA | — |
FERRIC CITRATE 210 MG TABLET | $6.2751 per EA | +0.34% |
Frequently Asked Questions
What is Ferric Citrate used to treat?
Ferric Citrate is used to treat iron-deficiency anemia and hematologic pregnancy complications, per the National Library of Medicine's MED-RT classification.
When did Ferric Citrate become available as a generic?
FDA approved the first generic Ferric Citrate (ANDA) on Mar 11, 2026. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Ferric Citrate?
In 2024, Medicare Part D spent $132 million on Ferric Citrate across 73,000 claims for 17,000 beneficiaries.
How many Ferric Citrate products are on the market?
The Ferric Citrate drug market contains 2 NDCs from 2 manufacturers — 1 generic and 1 brand product.
What is the price range for Ferric Citrate?
NADAC reference prices for Ferric Citrate range from $6.2751 to $7.4809 per EA — a 19% difference between cheapest and most expensive.
Is generic Ferric Citrate cheaper than brand?
The average generic NADAC for Ferric Citrate is $6.2751 per EA, versus $7.4809 for brand-labeled products — generic is about 16% cheaper on average.
Which manufacturers make Ferric Citrate?
2 manufacturers list Ferric Citrate in NADAC. Ranked by number of NDCs, the largest are Akebia Therapeutics, Inc. (1), Mylan Pharmaceuticals Inc. (1).
How has the price of Ferric Citrate changed recently?
Over the past 7 days, 2 Ferric Citrate NDCs rose and 0 fell, with a market-wide average change of +0.3%.